Factors associated with arm swelling in patients undergoing surgery and radiotherapy for breast cancer within the FAST-Forward trial nodal sub-study
Abstract
Purpose/objective: The FAST-Forward randomised nodal sub-study primary analysis showed non-inferiority for 5-year patient-reported arm/hand swelling following adjuvant breast/chest wall and axillary radiotherapy given in 26 Gy in 5 fractions (Fr) over 1 week compared to 40 Gy in 15Fr over 3 weeks. This subsequent analysis investigates the association between patient, tumour and treatment factors and development of long-term arm/hand swelling.
Material/methods: Data from 469 patients randomised to adjuvant radiotherapy 40 Gy/15Fr, 27 Gy/5Fr or 26 Gy/5Fr to breast/chest wall and axilla (any or all levels 1-4) in the FAST-Forward nodal sub-study were included. DICOM-RT data were collected prospectively. ESTRO-defined axillary nodal levels 1-4, the axillary-lateral thoracic vessel juncture (ALTJ), and visible seroma were contoured retrospectively. Mean, maximum and minimum doses were extracted. Univariable and stepwise multivariable logistic regression were used to identify predictors of 5-year arm swelling.
Results: At 5 years, moderate/marked arm/hand swelling was reported by 39/299 (13%) patients and clinician-reported arm lymphoedema by 45/346 (13%). Multivariable analysis identified axillary lymph node dissection (ALND) (OR 3.70, 95% CI [1.61-8.48], p = 0.002) and BMI ≥ 35 kg/m2 (OR 3.31 [1.08-10.12], p = 0.036) as significant predictors of 5-year patient-reported moderate/marked arm/hand swelling. For 5-year clinician-reported arm lymphoedema, multivariable analysis…
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design. Reported size: 469 participants or records.
Read the paper
Related studies
- Preliminary Toxicity Analysis of 3DCRT versus IMRT on the High Dose Arm of the RTOG 0126 Prostate Cancer Trial
- Adaptive Radiotherapy for Head and Neck Cancer: Initial Clinical Outcomes from a Prospective Trial
- American Association of Physicists in Medicine Task Group 263: Standardizing Nomenclatures in Radiation Oncology
- Motion Management Strategies and Technical Issues Associated with Stereotactic Body Radiotherapy of Thoracic and Upper Abdominal Tumors: A Review from NRG Oncology
- High-dose-rate interstitial brachytherapy as a monotherapy for localized prostate cancer: treatment description and preliminary results of a phase I/II clinical trial
- Highly efficient training, refinement, and validation of a knowledge-based plan quality control system for radiotherapy clinical trials
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.